Background: Point-of-care (POC) tests for sexually transmitted infections may increase timely diagnosis, treatment and partner notification, and thereby reduce community infection rates. With new, portable and highly accurate molecular diagnostic technology available through the GeneXpert®, we designed TTANGO (Test, Treat ANd GO), to measure the effectiveness, cost-effectiveness, cultural and operational acceptability of POC testing for chlamydia (CT) and gonorrhoea (NG) in remote Australian Aboriginal communities, where these infections occur at high levels. The trial employs a crossover, randomised controlled design at 12 health services in remote Australia. We describe the preparatory phase of the trial.
|Number of pages||1|
|Publication status||Published - 23 Oct 2013|
|Event||Australasian Sexual Health Conference - Darwin, Australia|
Duration: 21 Oct 2013 → 25 Oct 2013
|Conference||Australasian Sexual Health Conference|
|Period||21/10/13 → 25/10/13|